Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection.

Vaccine(2014)

引用 33|浏览1
暂无评分
摘要
•The immunogenicity and efficacy of IIV are not completely satisfactory in children.•OM-85 BV does not seem to increase the humoral and cell-mediated immune response to IIV.•Combined OM-85 and IIV seems to reduce respiratory morbidity in children with RRTIs.•Combined OM-85 and IIV seems to be safe and well tolerated.
更多
查看译文
关键词
Bacterial lysate,Children,Influenza,Influenza vaccine,OM-85 BV,Recurrent respiratory tract infection
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要